Overactive PDGFRα and PDGFRβ promote distinct phenotypes of skeletal muscle fibrosis and stiffness, with PDGFRβ also driving muscle growth
American Journal of Physiology-Cell Physiology · 2026
DOI: 10.1152/ajpcell.00035.2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2026. Verfasst von Mariola Gimla und 10 weiteren Autor:innen. Beteiligte Einrichtung: Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States. Hauptthemen laut MEDLINE: Muscle, Skeletal, Receptor, Platelet-Derived Growth Factor beta, Receptor, Platelet-Derived Growth Factor alpha, Muscle Development. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Biomedical Laboratory Research and Development, VA Office of Research and Development (BLRD), NIA NIH HHS.
Abstract (Originalsprache)
This study demonstrates that overactive PDGFRα and PDGFRβ signaling drive distinct and sex-specific skeletal muscle remodeling phenotypes. Overactive PDGFRα induces robust fibrosis characterized by increased insoluble and cross-linked collagen, elevated LOX and AGE levels, and marked muscle stiffness. Thus, establishing a new model to study skeletal muscle fibrosis. Overactive PDGFRβ unexpectedly promoted skeletal muscle hypertrophy and reduced fat mass with minimal fibrosis, revealing a previously unrecognized role in regulating muscle growth in vivo.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States.
- FSU Department of Health, Nutrition, and Food Sciences, Florida State University, Tallahassee, Florida, United States.
- Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, United States.
- The Oklahoma VA Medical Center, Oklahoma City, Oklahoma, United States.
ORCID-Profile: Mariola Gimla, Szczepan Olszewski, Jacob L Brown, Christiana J Raymond-Pope, Lorin E Olson, Jordan D Fuqua, Benjamin F Miller
Förderung
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- Biomedical Laboratory Research and Development, VA Office of Research and Development (BLRD)
- NIA NIH HHS
- BLRD VA
- NIAMS NIH HHS
- HHS | NIH | National Institute on Aging (NIA)
Zitieren
APA
Gimla, M., Olszewski, S., Brown, J. L., Raymond-Pope, C. J., Rigsby, S., Peelor, F. F., Kwon, H. R., Yao, L., Olson, L. E., Fuqua, J. D., & Miller, B. F. (2026). Overactive PDGFRα and PDGFRβ promote distinct phenotypes of skeletal muscle fibrosis and stiffness, with PDGFRβ also driving muscle growth. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00035.2026
Vancouver
Gimla M, Olszewski S, Brown JL, Raymond-Pope CJ, Rigsby S, Peelor FF, et al. Overactive PDGFRα and PDGFRβ promote distinct phenotypes of skeletal muscle fibrosis and stiffness, with PDGFRβ also driving muscle growth. American Journal of Physiology-Cell Physiology. 2026. doi:10.1152/ajpcell.00035.2026
BibTeX
@article{Gimla2026,
author = {Gimla, Mariola and Olszewski, Szczepan and Brown, Jacob L and Raymond-Pope, Christiana J and Rigsby, Sandra and Peelor, Frederick F and Kwon, Hae Ryong and Yao, Longbiao and Olson, Lorin E and Fuqua, Jordan D and Miller, Benjamin F},
title = {Overactive PDGFRα and PDGFRβ promote distinct phenotypes of skeletal muscle fibrosis and stiffness, with PDGFRβ also driving muscle growth},
journal = {American Journal of Physiology-Cell Physiology},
year = {2026},
doi = {10.1152/ajpcell.00035.2026}
}
EUVIMED